Cisplatin Cross-Linked Multifunctional Nanodrugplexes for Combination Therapy-Reference-Cited by-同舟云学术

Cisplatin Cross-Linked Multifunctional Nanodrugplexes for Combination Therapy

Published:2017-03-01 Issue:10 Volume:9 Page:8547-8555
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Zhang Weiqi¹^ORCID,Tung Ching-Hsuan¹^ORCID

Affiliation:

1. Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, 413 East 69th Street, Box 290, New York, New York 10021, United States

Funder

National Institute of General Medical Sciences

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.6b16500

Reference34 articles.

1. Cancer nanomedicine: from targeted delivery to combination therapy

2. Advances in Combination Therapies Based on Nanoparticles for Efficacious Cancer Treatment: An Analytical Report

3. Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology

4. Polysaccharides as building blocks for nanotherapeutics

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A refreshing approach to understanding the action on DNA of vanadium (IV) and (V) complexes derived from the anticancer VCpCl;Journal of Inorganic Biochemistry;2024-12

2. Harnessing the CD44-targeted delivery of self-assembled hyaluronan nanogel to reverse the antagonism between Cisplatin and Gefitinib in NSCLC cancer therapy;Carbohydrate Polymers;2024-11

3. Biodegradable Long-Circulating Nanoagonists Optimize Tumor-Tropism Chemo-Metalloimmunotherapy for Boosted Antitumor Immunity by Cascade cGAS-STING Pathway Activation;ACS Nano;2024-08-16

4. Co-assembly of cisplatin and dasatinib in hyaluronan nanogel to combat triple negative breast cancer with reduced side effects;International Journal of Biological Macromolecules;2024-06

5. Cisplatin-Based Combination Therapy for Enhanced Cancer Treatment;Current Drug Targets;2024-05